Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 3 |
2019 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Systemic delivery and SPECT/CT in vivo imaging of 125I-labelled oncolytic adenoviral mutants in models of pancreatic cancer.
Sci Rep. 2019 Sep 6;9(1):12840. doi: 10.1038/s41598-019-49150-9.
Sci Rep. 2019.
PMID: 31492884
Free PMC article.
Advances in oncolytic adenovirus therapy for pancreatic cancer.
Nattress CB, Halldén G.
Nattress CB, et al.
Cancer Lett. 2018 Oct 10;434:56-69. doi: 10.1016/j.canlet.2018.07.006. Epub 2018 Jul 5.
Cancer Lett. 2018.
PMID: 29981812
Review.
Item in Clipboard
Designer Oncolytic Adenovirus: Coming of Age.
Baker AT, Aguirre-Hernández C, Halldén G, Parker AL.
Baker AT, et al.
Cancers (Basel). 2018 Jun 14;10(6):201. doi: 10.3390/cancers10060201.
Cancers (Basel). 2018.
PMID: 29904022
Free PMC article.
Review.
Item in Clipboard
The Novel Oncolytic Adenoviral Mutant Ad5-3Δ-A20T Retargeted to αvβ6 Integrins Efficiently Eliminates Pancreatic Cancer Cells.
Man YKS, Davies JA, Coughlan L, Pantelidou C, Blázquez-Moreno A, Marshall JF, Parker AL, Halldén G.
Man YKS, et al.
Mol Cancer Ther. 2018 Feb;17(2):575-587. doi: 10.1158/1535-7163.MCT-17-0671.
Mol Cancer Ther. 2018.
PMID: 29367266
Item in Clipboard
Cite
Cite